Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
GAB
↓ PDF (Pro)Gabelli Equity Trust Inc. (The) Common Stock
Financial ServicesAsset ManagementUnited StatesNYSE
$5.76
+1.50%today
MKT CAP
$1.8B
+1.2% · 1Y
Full Financials
Trailing P/E5.8x
Forward P/E-
EV/EBITDA-
Price/Sales-
Dividend Yield1058.00%
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership0.6%
Institutional Ownership8.1%
Short % of Float3.62%
Days to Cover8.9d
1 Week+0.2%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| GABELLI MARIO JOSEPH | Director | Sale | 5,000 | $5.73 | $0.03M | 2024-11-25 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| LPL Financial LLC | institution | 1.43% | $0.03B | +2.15% | 2025-12-31 |
| Morgan Stanley | institution | 0.78% | $0.01B | +4.96% | 2025-12-31 |
| Commonwealth Equity Services, LLC | institution | 0.49% | $0.01B | +0.44% | 2026-03-31 |
| Philadelphia Trust Company | institution | 0.34% | $0.01B | -4.93% | 2025-12-31 |
| Gamco Investors, Inc ET AL | institution | 0.27% | $0.00B | +0.00% | 2025-12-31 |
| Cetera Investment Advisers | institution | 0.22% | $0.00B | +1.10% | 2025-12-31 |
| Wells Fargo & Company | institution | 0.21% | $0.00B | +0.97% | 2025-12-31 |
| Raymond James Financial, Inc. | institution | 0.21% | $0.00B | +1.25% | 2025-12-31 |
| Bank of America Corporation | institution | 0.19% | $0.00B | -5.23% | 2025-12-31 |
| Cambridge Investment Research Advisors Inc. | institution | 0.18% | $0.00B | +1.29% | 2026-03-31 |
| Unified Series Trust-Absolute CEF Opportunities | fund | 0.00% | $0.00B | +100.00% | 2026-02-28 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| CNS | $3.6B | 60 | 23.0 | 18.6 | - | - | - | - | 3.71% |
| SII | $3.8B | 24 | 43.5 | 25.5 | - | - | - | - | 112.00% |
| DNP | $4.0B | 100 | 9.3 | - | - | - | - | - | 7.36% |
| FHI | $4.2B | 100 | 10.8 | 9.8 | - | - | - | - | 2.52% |
| HLNE | $4.9B | 78 | 15.9 | 14.6 | 13.0 | 31.7% | 60% | 27.95 | 243.00% |
| MAIN | $5.2B | 89 | 10.4 | 14.0 | - | 17.0% | 100% | 82.45 | 5.43% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for GAB.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.